TrademarkDir
GALVUS MET
DEAD

Serial Number

88676987

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 1, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GALVUS MET Trademark

Serial Number: 88676987

GALVUS MET is a trademark filed by NOVARTIS AG on November 1, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 1, 2019

Registration Date

Not Registered

Published for Opposition

March 17, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 12, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 12, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2022 EXRA
SOU EXTENSION 5 GRANTED
Nov 17, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 16, 2022 AITU
SOU EXTENSION 5 FILED
Nov 7, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 7, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2022 EXRA
SOU EXTENSION 4 GRANTED
May 10, 2022 EX4G
SOU EXTENSION 4 FILED
May 10, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
May 10, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2021 EXRA
SOU EXTENSION 3 GRANTED
Nov 9, 2021 EX3G
SOU EXTENSION 3 FILED
Nov 9, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 9, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2021 EXRA
SOU EXTENSION 2 GRANTED
May 9, 2021 EX2G
SOU EXTENSION 2 FILED
May 9, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
May 9, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 13, 2020 EXRA
SOU EXTENSION 1 GRANTED
Nov 11, 2020 EX1G
SOU EXTENSION 1 FILED
Nov 11, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 11, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
ASSIGNED TO LIE
Feb 7, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 15, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 15, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 15, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 5, 2019 NWOS
NEW APPLICATION ENTERED
Nov 5, 2019 NWAP

Related Trademarks

More from this Owner

JOLBETZY

JOLBETZY

VAYBETRY

VAYBETRY

BEXJUXI

BEXJUXI

BEXJUXI

BEXJUXI

VISANSTA

VISANSTA

VISANSTA

VISANSTA